Resultado de búsqueda
Hace 1 día · The prevalence of metabolic syndrome in patients with schizophrenia has significantly increased and can be associated with severe complications such as chronic diseases and mortality. Despite numerous studies, a comprehensive estimate of the prevalence of metabolic syndrome in schizophrenia patients is lacking. Therefore, this study aimed to estimate the global prevalence of metabolic syndrome ...
Hace 1 día · Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from lectures. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.
Hace 1 día · A study published in The Journal of Psychopharmacology detailed how participants, through guided psilocybin sessions, experienced significant reductions in grief intensity. The psychedelic experience often involved a deep, almost tangible connection to the deceased, facilitating a cathartic release of pent-up emotions.
Hace 1 día · A psychoactive drug, mind-altering drug, or consciousness-altering drug is a chemical substance that changes brain function and results in alterations in perception, mood, consciousness, cognition, or behavior. [1] . This category of drugs includes psychotropic drugs (a term often used interchangeably with psychoactive drug) and narcotic drugs.
Hace 5 días · An investigation of the biological mechanisms and behavioral effects of psychoactive substances. Topics covered will include principles of pharmacology, research methods in psychopharmacology, mechanisms of drug action, drug abuse and addiction, and clinical applications.
Hace 4 días · Benzylpiperazine ( BZP) is a substance often used as a recreational drug and is known to have euphoriant and stimulant properties. Several studies conducted between 2000 and 2011 found that the effects of BZP are similar to amphetamine, although BZP's dosage is roughly 10 times higher by weight. [5] [6]
Hace 2 días · This is the second phase 3 study to show improvement in MADRS scores for patients who take lumateperone with their antidepressants. In Study 501, 485 patients with major depressive disorder were randomized to receive 42 mg of lumateperone or placebo once per day along with their usual antidepressants.At week 6, patients in the lumateperone group experienced a mean reduction in MADRS score of ...
